Skip to main content
WoMWeb of Medicine
SearchGraphHistory
Neurocritical Care›Condition·Updated Apr 17, 2026·v1

Cerebral Edema

Cerebral edema is a critical increase in brain volume due to fluid accumulation, leading to elevated intracranial pressure and potential herniation. Management requires rapid identification via CT/MRI and a tiered treatment approach using hyperosmolar agents and surgical decompression.

High Evidence298 references·10,041 words·41 min read·v1
neurocritical careintracranial pressurestroketraumatic brain injuryherniation

Quick Reference

RxDrug of choiceMannitol 20% (0.5-1.0 g/kg) or Hypertonic Saline 3% (250 mL bolus)
AltAlternativesDexamethasone (for tumors), Pentobarbital (for refractory ICP)
⊘AvoidHypotonic fluids (D5W, 0.45% NS); Steroids in TBI/Stroke
DxTest of choiceMRI with DWI/ADC (characterization); NCCT (acute mass effect)
ScKey scoreASPECTS (stroke), GCS (consciousness), Midline Shift (mm)
→When to referGCS ≤ 8, midline shift > 5 mm, or failure of Tier 1 medical therapy
Cerebral edema is a neurosurgical emergency; management focuses on osmotic fluid withdrawal and surgical decompression to prevent fatal herniation.
Cerebral edema is a life-threatening secondary complication of various neurological insults, characterized by an abnormal accumulation of fluid within the brain parenchyma. Because the brain is encased in the rigid, non-expandable cranium, even minor increases in tissue volume can lead to a precipitous rise in intracranial pressure (ICP), resulting in brain herniation, permanent neurological deficit, or death. Clinically, it is categorized into cytotoxic (cellular swelling due to energy failure), vasogenic (blood-brain barrier disruption), interstitial (hydrocephalic), and osmotic types. Management is time-critical and follows a tiered approach: initial physiological stabilization, hyperosmolar therapy (mannitol or hypertonic saline), and, in refractory cases, surgical decompression. Identifying patients at risk for malignant cerebral edema (MCE) following large-vessel strokes is paramount for early intervention.

Overview and Recommendations

Background

  • •Define cerebral edema as an increase in brain volume resulting from fluid accumulation, which is a secondary response to primary insults such as , (TBI), or metabolic disturbances.
  • •Distinguish between cytotoxic edema, which involves intracellular water shift due to Na+/K+-ATPase pump failure (common in early ischemia), and vasogenic edema, which involves (BBB) breakdown allowing protein-rich fluid into the extracellular space (common in tumors and late-stage stroke).
  • •Recognize malignant cerebral edema (MCE) as a rapid-onset, life-threatening form of swelling typically following large-vessel occlusions (e.g., middle cerebral artery), carrying a mortality rate exceeding 80% without aggressive intervention.
  • •Identify the role of molecular drivers such as the SUR1-TRPM4 cation channel and Aquaporin-4 (AQP4) water channels, which facilitate the movement of water into the brain parenchyma during the acute phase of injury.
  • •Understand the clinical significance of the Monro-Kellie doctrine, which states that the sum of volumes of brain, CSF, and intracerebral blood is constant; an increase in one (edema) must be compensated by a decrease in others or ICP will rise exponentially.

Evaluation

  • •Suspect cerebral edema in any patient with a sudden decline in Glasgow Coma Scale (GCS) score, new focal neurological deficits, or signs of increased ICP such as worsening headache, nausea, and projectile vomiting.
  • •Ask about the temporal progression of symptoms; edema typically peaks between 24 and 72 hours following an acute ischemic or traumatic insult.
  • •Examine for the Cushing Triad—hypertension, bradycardia, and irregular respirations—which is a late and ominous sign of impending brainstem herniation.
  • •Perform a pupillary exam to check for anisocoria or a fixed, dilated pupil, which suggests uncal herniation and compression of the third cranial nerve.
  • •Obtain a non-contrast CT (NCCT) head immediately as the first-line imaging to assess for midline shift, sulcal effacement, and ventricular compression.
  • •Measure the Optic Nerve Sheath Diameter (ONSD) using point-of-care ultrasound (POCUS); a diameter > 5.5 mm is highly suggestive of elevated ICP (> 20 mmHg).
  • •Order an MRI with Diffusion-Weighted Imaging (DWI) and Apparent Diffusion Coefficient (ADC) maps to differentiate cytotoxic (low ADC) from vasogenic (high ADC) edema.
  • •Calculate the Alberta Stroke Program Early CT Score (ASPECTS) in stroke patients; a score of 1–5 or an ischemic core volume > 80 mL indicates a high risk for malignant progression.
  • •Monitor serum sodium and osmolality frequently, especially in patients with or those undergoing hyperosmolar therapy, to avoid rapid osmotic shifts.
  • •Rule out metabolic mimics and contributors, such as severe hyperammonemia in or rapid glucose drops in (DKA).

Management

  • •Elevate the head of the bed to 30 degrees and maintain the neck in a neutral midline position to optimize venous outflow from the cranium.
  • •Administer Mannitol 20% at a dose of 0.5 to 1.0 g/kg IV bolus over 15 minutes for acute neurological deterioration; repeat every 4–6 hours as needed while maintaining serum osmolality < 320 mOsm/kg.
  • •Utilize Hypertonic Saline (HTS) 3% as an alternative or adjunct, typically given as a 250 mL bolus or 3 mL/kg, targeting a serum sodium of 145–155 mEq/L.
  • •Administer Dexamethasone 10 mg IV initially, followed by 4 mg every 6 hours, specifically for vasogenic edema associated with primary or metastatic brain tumors.
  • •Avoid corticosteroids in patients with acute ischemic stroke or traumatic brain injury, as they have shown no benefit and may increase the risk of infection and hyperglycemia.
  • •Maintain normothermia (37.0°C) aggressively, as fever increases cerebral metabolic demand and exacerbates secondary brain injury.
  • •Provide adequate analgesia and sedation (e.g., Propofol infusion 5–50 mcg/kg/min) to reduce sympathetic surges and metabolic rate.
  • •Ensure Cerebral Perfusion Pressure (CPP) remains between 60 and 70 mmHg by maintaining adequate mean arterial pressure (MAP) with vasopressors if necessary.
  • •Avoid hypotonic fluids such as 0.45% normal saline or D5W, which decrease serum osmolarity and promote water movement into the brain.
  • •Refer for urgent Decompressive Hemicraniectomy in patients < 60 years old with malignant MCA syndrome who deteriorate within 48 hours despite medical therapy.
  • •Implement brief hyperventilation (target PaCO2 30–35 mmHg) only as a temporary bridge to definitive surgical or osmotic therapy during an acute herniation crisis.
  • •Monitor for seizures, which can worsen edema; initiate Levetiracetam 1500 mg IV bolus followed by 500–1500 mg twice daily if clinical or electrographic seizures occur.
  • •Consider external ventricular drain (EVD) placement for CSF diversion if interstitial edema from obstructive is present.
  • •Limit sodium correction in chronic hyponatremia to < 8–10 mEq/L per 24 hours to prevent osmotic demyelination syndrome.
  • •Discharge criteria include stabilized ICP for > 48 hours without hyperosmolar therapy, improving GCS, and radiographic resolution of midline shift.

Board Review — High Yield

  • •Cytotoxic Edema — Intracellular swelling due to Na+/K+ pump failure; appears as restricted diffusion (low ADC) on MRI.
  • •Vasogenic Edema — Extracellular fluid from BBB breakdown; predominantly involves white matter and is steroid-responsive in oncology.
  • •Cushing Triad — Hypertension, bradycardia, and irregular respirations; indicates late-stage increased ICP and impending herniation.
  • •Monro-Kellie Doctrine — The rigid skull creates a fixed volume; any increase in brain volume must be offset by decreased CSF or blood.
  • •Malignant MCA Syndrome — Rapid swelling after large stroke; decompressive hemicraniectomy within 48 hours reduces mortality in those < 60 years.
  • •Optic Nerve Sheath Diameter (ONSD) — Ultrasound measurement > 5.5 mm correlates with ICP > 20 mmHg.
  • •Interstitial Edema — Seen in obstructive hydrocephalus; fluid is forced across the ependymal lining into periventricular white matter.

Deep Dive — Evidence Details

References

  1. [1]

    Zhang G, Chen C, Ren X et al.. “Effects of Intensive Blood Pressure Lowering on Brain Swelling in Thrombolyzed Acute Ischemic Stroke: The ENCHANTED Results.” Stroke (2025). PMID: 40177745 ↗

    L1bRCTCited in: Definition, Synonyms, and Classification, History and Physical Examination, Prognosis and Long-term Outcomes, Landmark Trials and Key Evidence
  2. [2]

    Peng X, Zhu R, Zhang K et al.. “Global collaboration and innovation in malignant cerebral edema research: a bibliometric perspective.” Frontiers in neurology (2025). PMID: 40771971 ↗

    L2aSR_OBSCited in: Definition, Synonyms, and Classification
  3. [3]

    Krishnan K, Grace E, Woodhouse L et al.. “Baseline characteristics of patients recruited to the mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH) trial.” Clinical neurology and neurosurgery (2026). PMID: 41690237 ↗

    L1bRCTCited in: Definition, Synonyms, and Classification, Medical Management, Prognosis and Long-term Outcomes
  4. [4]

    Krishnan K, Grace E, Woodhouse L et al.. “Mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH): protocol for a prospective, randomised, open-label, blinded-endpoint phase IIb trial.” BMJ open (2025). PMID: 40721251 ↗

    L2bTRIAL_NONRANDOMCited in: Definition, Synonyms, and Classification, Medical Management, Prognosis and Long-term Outcomes
  5. [5]

    Ibarra F, Hsu J, Jassal A et al.. “Comparison of 8.4% Sodium Bicarbonate vs. 3% Sodium Chloride in Severe Hyponatremia: A Retrospective Cohort Study.” Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2026). PMID: 41937305 ↗

    L2bCOHORTCited in: Definition, Synonyms, and Classification, Etiology and Triggering Factors
  6. [6]

    Lu L, Ou H, Wang X et al.. “The impact of sulfonylureas on survival in patients with severe ischemic stroke and type 2 diabetes: A retrospective study based on the MIMIC-IV database.” Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2025). PMID: 40618539 ↗

    L2bCOHORTCited in: Definition, Synonyms, and Classification, Epidemiology and Risk Factors
  7. [7]

    Qin W, Zhao Y, Du J et al.. “Insights into the potential pathogenesis and therapeutic implications of ferroptosis in brain microvascular endothelial cells during stroke.” Frontiers in immunology (2026). PMID: 41836429 ↗

    L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification, Etiology and Triggering Factors, Pathophysiology
  8. [8]

    Sterns RH, Rondon-Berrios H. “Revisiting New Data on the Mortality Benefit of Rapid Correction of Hyponatremia: Déjà Vu All Over Again.” American journal of kidney diseases : the official journal of the National Kidney Foundation (2026). PMID: 41093163 ↗

    L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification, Epidemiology and Risk Factors
  9. [9]

    Prasath S, Harsha SP, Swamy AM et al.. “Revisiting the use of steroids in oncology.” Medical oncology (Northwood, London, England) (2025). PMID: 41452544 ↗

    L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification, Medical Management
  10. [10]

    García Ríos CA, Leon-Rojas JE. “Aquaporin-4 in Stroke and Brain Edema-Friend or Foe?” International journal of molecular sciences (2025). PMID: 40943104 ↗

    L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification, Pathophysiology
  11. [11]

    Yang Z, Li P, Wei J. “Perceiving traumatic brain injury from glymphatic system.” Molecular psychiatry (2025). PMID: 40745390 ↗

    L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification, Pathophysiology
  12. [12]

    Datta D, John CC. “Pathogenesis of brain injury in cerebral malaria: emerging mechanisms and implications for intervention.” Current opinion in infectious diseases (2025). PMID: 40742185 ↗

    L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification, Pathophysiology
  13. [13]

    Coupland KG, Amell MF, Spratt NJ. “Brain fluid physiology in ischaemic stroke; more than just oedema.” Fluids and barriers of the CNS (2025). PMID: 40533800 ↗

    L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification
  14. [14]

    Sen BK, Pan K, Chakravarty A. “Hepatic Encephalopathy: Current Thoughts on Pathophysiology and Management.” Current neurology and neuroscience reports (2025). PMID: 40153081 ↗

    L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification
  15. [15]

    Kasuda K, Saito R, Nishiyama T et al.. “Liver Transplantation for Acute Liver Failure After Intentional Iron Overdose: A Case Report and Literature Review.” Pediatric transplantation (2025). PMID: 41039699 ↗

    L4CASE_REPORTCited in: Definition, Synonyms, and Classification
  16. [16]

    Barragán C, González-Gómez S, Barrera A et al.. “Reversible intramyelinic cytotoxic edema in a patient with traumatic brain injury.” Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2025). PMID: 40610848 ↗

    L4CASE_REPORTCited in: Definition, Synonyms, and Classification, Diagnosis and Workup
  17. [17]

    Micovic M, Zivkovic B, Vukasinovic I et al.. “Trauma-Induced Cerebellar Edema: A Rare Presentation of Infratentorial Developmental Venous Anomaly in a Pediatric Patient.” Cerebellum (London, England) (2025). PMID: 40387982 ↗

    L4CASE_REPORTCited in: Definition, Synonyms, and Classification, Diagnosis and Workup
  18. [18]

    Zhang Y, Chen R, Kong X et al.. “Rapid-onset hypernatremia induced by central diabetes insipidus leading to osmotic demyelination syndrome: a case report.” Frontiers in medicine (2025). PMID: 40370728 ↗

    L4CASE_REPORTCited in: Definition, Synonyms, and Classification
  19. [19]

    Kurdi M, Kabli A, Alkhotani A et al.. “Impact of corticosteroid administration on glioblastoma progression before and after adjuvant treatments: recent updates on contradictory findings and mechanistic interactions.” Frontiers in oncology (2026). PMID: 41847699 ↗

    L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification
  20. [20]

    Silva BKO, de Carvalho MCS, Delgado AF et al.. “Neurologic monitoring in children and adolescents with hepatic failure: new mechanisms and non-invasive approach.” Clinics (Sao Paulo, Brazil) (2025). PMID: 41297473 ↗

    L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification, Diagnosis and Workup
  21. [21]

    Zeng L, Yin Z, Li W et al.. “Glymphatic system function in patients with ischemic stroke evaluated by the DTI-ALPS method: a comprehensive review.” Frontiers in neurology (2025). PMID: 41064036 ↗

    L5REVIEW_NARRATIVECited in: Definition, Synonyms, and Classification
  22. [22]

    Abdelhakim N, Galecio-Castillo M, Kalakoti P et al.. “Cytotoxic Edema and Intra-parenchymal Hemorrhage: A Mediated Pathway to Mortality and Functional Outcome in Cerebral Venous Sinus Thrombosis- A sub-analysis of the CLOT-VENUS Registry.” Translational stroke research (2026). PMID: 41975110 ↗

    L5OTHERCited in: Definition, Synonyms, and Classification
  23. [23]

    Tan Y, Ye H, Ge Q et al.. “Multimodal MR Imaging Reveals the Mechanisms of Post-Cardiac-Arrest Brain edema: Ferroptosis-Mediated BBB Disruption and AQP4 Dysfunction.” Journal of magnetic resonance imaging : JMRI (2026). PMID: 41933462 ↗

    L5OTHERCited in: Definition, Synonyms, and Classification
  24. [24]

    Shen W, Jiang C, Liu X et al.. “Astragaloside IV alleviates post-traumatic cytotoxic edema via inhibition of AQP4 expression and subcellular localization.” Phytomedicine : international journal of phytotherapy and phytopharmacology (2026). PMID: 41916121 ↗

    L5OTHERCited in: Definition, Synonyms, and Classification
  25. [25]

    Nakagawa M, Tomura S, Toyooka T et al.. “Preconditioning Effect of Hydrogen Gas on Traumatic Brain Injury.” Journal of neurotrauma (2026). PMID: 41877520 ↗

    L5OTHERCited in: Definition, Synonyms, and Classification
  26. [26]

    Dayyani M, Filippov A, Zhang I et al.. “RAGE Inhibition Reduces Surgery-Induced Cerebral Edema After Glioma Resection.” Neurosurgery (2026). PMID: 41854274 ↗

    L5OTHERCited in: Definition, Synonyms, and Classification
  27. [27]

    Lin XY, Usman M, Ai L et al.. “Experimental Study on Changes in the Structure of the Blood-Brain Barrier after Treatment with Bevacizumab for Traumatic Cerebral Edema.” Neurocritical care (2026). PMID: 41673382 ↗

    L5OTHERCited in: Definition, Synonyms, and Classification
  28. [28]

    Poulain A, Riseth J, Emblem KE et al.. “Modeling glioma-induced impairments on the glymphatic system.” Fluids and barriers of the CNS (2026). PMID: 41612346 ↗

    L5OTHERCited in: Definition, Synonyms, and Classification, Etiology and Triggering Factors, Pathophysiology
  29. [29]

    Palazzo C, Pati R, Gatta RP et al.. “Acute Dehydration Drives Organ-Specific Modulation of Phosphorylated AQP4ex in Brain and Kidney.” International journal of molecular sciences (2026). PMID: 41596269 ↗

    L5OTHERCited in: Definition, Synonyms, and Classification, Pathophysiology
  30. [30]

    Cohen C, Debacker C, Le Berre A et al.. “Revisiting the Optimal Apparent Diffusion Coefficient Threshold for Ischemic Core Delineation.” Neurology (2026). PMID: 41453127 ↗

    L5OTHERCited in: Definition, Synonyms, and Classification, Etiology and Triggering Factors, Diagnosis and Workup
  31. [31]

    Hegazi A, Mohamed RG, Kashbour M et al.. “Efficacy and Safety of Glibenclamide on Functional Outcomes and Cerebral Edema following Ischemic and Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Medical principles and practice : international journal of the Kuwait University, Health Science Centre (2026). PMID: 40720947 ↗

    L1aSR_MA_RCTCited in: Epidemiology and Risk Factors, Prognosis and Long-term Outcomes
  32. [32]

    Sweety S, Panda S, Das RR. “Balanced electrolyte solution vs isotonic saline in the resuscitation of children with diabetic ketoacidosis: A randomized controlled trial.” World journal of clinical pediatrics (2026). PMID: 41884024 ↗

    L1bRCTCited in: Epidemiology and Risk Factors
  33. [33]

    Hou H, Feng B, Zang D et al.. “Safety and Feasibility of YC-6 in Patients With Large Hemispheric Infarction: A Randomized Clinical Trial.” Journal of the American Heart Association (2025). PMID: 41147407 ↗

    L1bRCTCited in: Epidemiology and Risk Factors, Prognosis and Long-term Outcomes, Landmark Trials and Key Evidence
  34. [34]

    Falcão L, Gomes PAL, Silva RAS et al.. “Assessing Glibenclamide's efficacy on functional recovery in aneurysmal subarachnoid hemorrhage: A meta-analysis of randomized controlled trials.” Clinical neurology and neurosurgery (2025). PMID: 40107191 ↗

    L1aSR_MA_RCTCited in: Epidemiology and Risk Factors, Prognosis and Long-term Outcomes
  35. [35]

    Mohammed HE, Haseeb ME, Bady Z et al.. “The Efficacy and Safety of Glibenclamide in Improving Cerebral Edema and Neurological Outcomes in Stroke: a GRADE-Evaluated Systematic Review and Meta-analysis with Subgroup Analysis.” Neurocritical care (2025). PMID: 40629214 ↗

    L2aSR_OBSCited in: Epidemiology and Risk Factors
  36. [36]

    Chen Y, Mofatteh M, Dai Y et al.. “Decompressive craniectomy after endovascular thrombectomy in acute ischemic stroke: a systematic review.” Acta neurochirurgica (2025). PMID: 40622611 ↗

    L2aSR_OBSCited in: Epidemiology and Risk Factors, Surgical Management
  37. [37]

    Song W, Liu Y, Kang C et al.. “Efficacy and safety of Shuxuening injection in intracerebral hemorrhage: a systematic review and meta-analysis.” Frontiers in pharmacology (2025). PMID: 40458793 ↗

    L2aSR_OBSCited in: Epidemiology and Risk Factors
  38. [38]

    Shafieioun A, Ghaffari H, Baradaran M et al.. “Predictive power of artificial intelligence for malignant cerebral edema in stroke patients: a CT-based systematic review and meta-analysis of prevalence and diagnostic performance.” Neurosurgical review (2025). PMID: 40128510 ↗

    L2aSR_OBSCited in: Epidemiology and Risk Factors, Diagnosis and Workup
  39. [39]

    Dupont J, Dinkova M, Tabillon C et al.. “Infection following a stereotactic brain biopsy: Myth or reality? Retrospective study between 2009 and 2023.” Anaesthesia, critical care & pain medicine (2026). PMID: 41022203 ↗

    L2bCOHORTCited in: Epidemiology and Risk Factors, Medical Management, Surgical Management
  40. [40]

    Qin J, Li C, Fu J et al.. “Construction and application of a nomogram model for predicting postoperative cerebral edema in meningiomas based on radiomics and clinical features.” Acta radiologica (Stockholm, Sweden : 1987) (2025). PMID: 40474660 ↗

    L1bRCTCited in: Epidemiology and Risk Factors, Diagnosis and Workup, Prognosis and Long-term Outcomes
  41. [41]

    Fustiñana AL, Echeveste JR, Pedalino J et al.. “Implementation of a Clinical Practice Guideline for diabetic ketoacidosis at a tertiary pediatric hospital: a before-after study.” Andes pediatrica : revista Chilena de pediatria (2025). PMID: 41842793 ↗

    L1cGUIDELINECited in: Epidemiology and Risk Factors, Special Populations
  42. [42]

    Bicknell BT, Malepati A, Taylor MA et al.. “Diagnostic and Prognostic Value of Retinal and Intracranial Hemorrhages in Abusive Head Trauma: A Retrospective Study.” Journal of pediatric ophthalmology and strabismus (2026). PMID: 41817138 ↗

    L2bCOHORTCited in: Epidemiology and Risk Factors
  43. [43]

    Feininger ES, May CC, Hinduja A et al.. “Risk factor analysis of hypertonic saline non-responders for the treatment of cerebral edema: a retrospective cohort study.” International journal of clinical pharmacy (2026). PMID: 41379290 ↗

    L2bCOHORTCited in: Epidemiology and Risk Factors, Medical Management, Prognosis and Long-term Outcomes
  44. [44]

    Raja J, Mishra R, Kamath S et al.. “Incidence, predictors, and impact of cerebral edema during the early brain injury phase of aneurysmal subarachnoid hemorrhage: A retrospective cohort study.” Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2026). PMID: 41352133 ↗

    L2bCOHORTCited in: Epidemiology and Risk Factors
  45. [45]

    Liu Z, Lin Y, Duan X et al.. “Predictors of Malignant Cerebral Edema Following Mechanical Thrombectomy in Acute Ischemic Stroke: A Retrospective Study and Nomogram Development.” World neurosurgery (2026). PMID: 41274648 ↗

    L2bCOHORTCited in: Epidemiology and Risk Factors, Etiology and Triggering Factors, Prognosis and Long-term Outcomes
  46. [46]

    Li J, Zhang W, Tang SN et al.. “Endovascular Interventional Thrombolysis Combined With Mild Hypothermia Induced by Intravascular Hypothermia Saline Fails to Improve Outcomes in the Acute Large Vessel Occlusive Cerebral Infarction Patients: A Single-Center Prospective Case-Control Study.” Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2025). PMID: 40999632 ↗

    L3bCASE_CONTROLCited in: Epidemiology and Risk Factors, Medical Management, Prognosis and Long-term Outcomes
  47. [47]

    Lu R, Yan J, Wang S et al.. “Two cases of acute pancreatitis occurring during therapeutic hypothermia for severe brain injury: case report and literature review.” Frontiers in medicine (2026). PMID: 41919147 ↗

    L4CASE_REPORTCited in: Epidemiology and Risk Factors
  48. [48]

    Memarian S, Zolfaghari A, Gharib B et al.. “The incidence of cerebral edema in pediatric patients with diabetic ketoacidosis: a retrospective study.” BMC research notes (2025). PMID: 40205526 ↗

    L2bCOHORTCited in: Epidemiology and Risk Factors, Special Populations
  49. [49]

    Ali NM, Alhag MH, Mustafa AE et al.. “Prevalence, Clinical Profile, and Outcomes of Diabetic Ketoacidosis (DKA) in Pediatric ICU Patients in the Middle East: A Systematic Review and Meta-Analysis.” Cureus (2026). PMID: 41859577 ↗

    L2aSR_OBSCited in: Epidemiology and Risk Factors
  50. [50]

    Zhang X, Li C, Wang Y et al.. “No-reflow phenomenon after vessel recanalization in acute ischemic stroke: mechanisms, diagnosis, and treatment directions.” Journal of neurology (2026). PMID: 41915244 ↗

    L5REVIEW_NARRATIVECited in: Epidemiology and Risk Factors, Etiology and Triggering Factors
  51. [51]

    Trivedi A, Miyazawa BY, Zhang H et al.. “A Dried Platelet-Derived Biologic for Blood-Brain Barrier Repair and Hemorrhage Control Following TBI in Mice.” Blood (2026). PMID: 41843452 ↗

    L5OTHERCited in: Epidemiology and Risk Factors
  52. [52]

    Luo B, Cui W, Zhang M et al.. “Insular infarction synergistically amplifies malignant cerebral edema risk in anterior circulation large vessel occlusion.” Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2026). PMID: 41763340 ↗

    L5OTHERCited in: Epidemiology and Risk Factors, Prognosis and Long-term Outcomes
  53. [53]

    Al-Salahat A, Cheung R, Dilsaver DB et al.. “Factors associated with mortality in posterior reversible encephalopathy syndrome: a nationwide analysis.” Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2026). PMID: 41731090 ↗

    L5OTHERCited in: Epidemiology and Risk Factors, History and Physical Examination, Differential Diagnosis, Medical Management
  54. [54]

    Schmitt LG, Dohopolski M, de Vis J et al.. “Adaptive MRI-Guided Reirradiation for High-Risk Recurrent Grade 4 Gliomas: Early Clinical Outcomes and Volumetric Response.” International journal of radiation oncology, biology, physics (2026). PMID: 41663034 ↗

    L5OTHERCited in: Epidemiology and Risk Factors
  55. [55]

    Liang J, Zhong S, Lian Y et al.. “Episodic encephalopathy in NOTCH2NLC-related neuronal intranuclear inclusion disease: Clinical spectrum and a proposed classification framework.” Journal of the neurological sciences (2026). PMID: 41455460 ↗

    L5OTHERCited in: Epidemiology and Risk Factors, Diagnosis and Workup
  56. [56]

    Loggini A, Del Brutto VJ, Velez FGS et al.. “Early gastrostomy is associated with more efficient healthcare resource utilization in nontraumatic intracerebral hemorrhage patients.” Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2026). PMID: 41448379 ↗

    L5OTHERCited in: Epidemiology and Risk Factors, Medical Management, Prognosis and Long-term Outcomes
  57. [57]

    Burst V, Rabii R, Peto-Madew J et al.. “Severe Hyponatremia in the Emergency Department Incidence of Cerebral Edema and Risk of Osmotic Demyelination Syndrome.” Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2026). PMID: 41069084 ↗

    L5OTHERCited in: Epidemiology and Risk Factors, Medical Management
  58. [58]

    Takeuchi I, Muraoka S, Kinoshita F et al.. “Efficacy of combined clazosentan and cilostazol therapy for cerebral vasospasm after subarachnoid hemorrhage: a retrospective multicenter registry study.” Journal of neurosurgery (2026). PMID: 40972040 ↗

    L5OTHERCited in: Epidemiology and Risk Factors, Medical Management
  59. [59]

    Dabbagh Ohadi MA, Soleimani S, Kakoienejad MM et al.. “Clinical benefits of photodynamic therapy in glioblastoma: systematic review and meta-analysis.” Journal of neurosurgery (2026). PMID: 41569684 ↗

    L2aSR_OBSCited in: Etiology and Triggering Factors, Medical Management, Prognosis and Long-term Outcomes
  60. [60]

    Li M, Pan Y, Jiang G et al.. “Bevacizumab plus chemotherapy versus chemotherapy in untreated advanced non-squamous non-small-cell lung cancer patients with brain metastases (BAP BRAIN): an open-label, randomized, multicenter, phase III study.” ESMO open (2025). PMID: 41270700 ↗

    L1bRCTCited in: Etiology and Triggering Factors, Medical Management, Landmark Trials and Key Evidence
  61. [61]

    Gigliotti MJ, Jareczek FJ. “Indications and Timing in Ischemic Infarction and Other Disorders.” Neurosurgery clinics of North America (2026). PMID: 41967892 ↗

    L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors
  62. [62]

    Yan X, Shen H, Zhao M et al.. “Time Is of the Essence: Temporal Dynamics of Epigenetic Landscapes as Therapeutic Targets in Traumatic Brain Injury.” ACS chemical neuroscience (2026). PMID: 41565603 ↗

    L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors
  63. [63]

    Arbogast A, Montoya Rush MN, Ghosh S et al.. “Cerebrovascular Unit Activation and Response Following Traumatic Brain Injury.” Shock (Augusta, Ga.) (2026). PMID: 41166163 ↗

    L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors
  64. [64]

    Shi Y, Liang T, Shi C et al.. “Molecular mechanisms of streptococcal disruption of the blood-brain barrier and their pathogenic role in bacterial meningitis.” Frontiers in immunology (2025). PMID: 41573555 ↗

    L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors, Pathophysiology
  65. [65]

    Henry DA. “Hyponatremia.” Annals of internal medicine (2025). PMID: 41359965 ↗

    L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors, Medical Management
  66. [66]

    Najjar M, Fleming M. “Pediatric stroke: From emergent evaluation to rehabilitation.” Current problems in pediatric and adolescent health care (2025). PMID: 41353016 ↗

    L5REVIEW_NARRATIVECited in: Etiology and Triggering Factors, Medical Management
  67. [67]

    Pang L, Xu X, Liu Y et al.. “A case report and literature review of neuropsychiatric lupus presenting with coma as the initial symptom.” Medicine (2026). PMID: 41560092 ↗

    L4CASE_REPORTCited in: Etiology and Triggering Factors
  68. [68]

    Chen Y, Yin X, Zhang E et al.. “Astrocyte-Derived Exosomal miR-211-5p Alleviates Blood-Brain Barrier Injury in a Rat Model of Traumatic Brain Injury.” CNS neuroscience & therapeutics (2026). PMID: 41954515 ↗

    L5OTHERCited in: Etiology and Triggering Factors, Pathophysiology
  69. [69]

    Bai J, Xie N, Hou Y et al.. “SnRNA-seq reveals the ameliorative effects of optimized Xueyu Jingshen formula on high altitude cerebral edema by modulating energy metabolism, inflammation and BBB integrity.” Phytomedicine : international journal of phytotherapy and phytopharmacology (2026). PMID: 41720010 ↗

    L5OTHERCited in: Etiology and Triggering Factors, Pathophysiology, Special Populations
  70. [70]

    Li X, Gao Y, Ye Y et al.. “Cyanidin-3-glucoside confers neuroprotection in ischemic stroke by targeting NOX4-mediated oxidative stress: A network pharmacology and experimental validation study.” Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2026). PMID: 41616469 ↗

    L5OTHERCited in: Etiology and Triggering Factors
  71. [71]

    Zhou YF, Yang SB, Zhang F et al.. “Microvascular endothelial metabolic dysfunction drives cerebral edema through bioenergetic failure after ischemia-reperfusion.” Theranostics (2026). PMID: 41608584 ↗

    L5OTHERCited in: Etiology and Triggering Factors
  72. [72]

    Malhotra AK, Nathens AB, Shakil H et al.. “Predicting Return Home After Moderate-to-Severe Traumatic Brain Injury.” Neurology (2026). PMID: 41604614 ↗

    L5OTHERCited in: Etiology and Triggering Factors, Prognosis and Long-term Outcomes
  73. [73]

    Xu X, Xu X, Ma J et al.. “Clinical Benefit of Thrombectomy in Large-Core Infarction Patients Is Mediated by Malignant Cerebral Edema Reduction.” Journal of the American Heart Association (2026). PMID: 41568548 ↗

    L5OTHERCited in: Etiology and Triggering Factors, Prognosis and Long-term Outcomes
  74. [74]

    Yu MJ, Xiong RQ, Wu JW et al.. “β-Hydroxybutyrate improves glymphatic system function and alleviates cerebral edema in mice after ischemic stroke.” Acta pharmacologica Sinica (2026). PMID: 41535708 ↗

    L5OTHERCited in: Etiology and Triggering Factors, Pathophysiology, Medical Management
  75. [75]

    Petersen NH, Begunova L, Olexa M et al.. “Autoregulation-Guided Blood Pressure Targets After Stroke Thrombectomy: Impact on Secondary Brain Injury and Neurologic Outcomes.” Neurology (2026). PMID: 41512207 ↗

    L5OTHERCited in: Etiology and Triggering Factors, History and Physical Examination, Prognosis and Long-term Outcomes
  76. [76]

    Shang H, Xu R, Niu H et al.. “20(S)-Protopanaxadiol regulating glucocorticoid receptor attenuates ischemic stroke injury by alleviating the autophagy-lysosomal pathway dysfunction and neuroinflammation.” Phytomedicine : international journal of phytotherapy and phytopharmacology (2026). PMID: 41499936 ↗

    L5OTHERCited in: Etiology and Triggering Factors
  77. [77]

    Jin L, Yang Z, Wei B et al.. “Amelioration of Post-Stroke Edema and Microcirculatory Dysfunction via Targeted AQP4 Inhibition While Preserving the Glymphatic System.” Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2026). PMID: 41387988 ↗

    L5OTHERCited in: Etiology and Triggering Factors, Pathophysiology
  78. [78]

    Banderwal R, Kumar A. “Neuroprotective mechanism of syringic acid targeting oxidative damage and neuroinflammation in an experimental model of traumatic brain injury.” Inflammopharmacology (2026). PMID: 41369867 ↗

    L5OTHERCited in: Etiology and Triggering Factors
  79. [79]

    Zhang X, Liu B, Shao D et al.. “Anti-inflammatory and neuroprotective effect of bryodulcosigenin against cerebral ischemia/reperfusion injury via modulation of inflammatory signaling pathways.” Inflammopharmacology (2026). PMID: 41269478 ↗

    L5OTHERCited in: Etiology and Triggering Factors, Pathophysiology
  80. [80]

    Han N, Zhang X, Zhang Y et al.. “Predicting early severe midline shift in acute ischemic stroke Within 24 h of endovascular thrombectomy.” Neuroradiology (2026). PMID: 41201490 ↗

    L5OTHERCited in: Etiology and Triggering Factors, Diagnosis and Workup, Prognosis and Long-term Outcomes
  81. [81]

    Viveros-Bartolomé JM, Pérez-Mora S, Alquisiras-Burgos I et al.. “Extract of Bacopa procumbens Mitigates Brain Injury and Improves Functional Outcomes Following Ischemia-Reperfusion.” International journal of molecular sciences (2025). PMID: 41465215 ↗

    L5OTHERCited in: Etiology and Triggering Factors
  82. [82]

    Li M, Huo X, Zhao X et al.. “Nr1d1 Regulates Microglia M1/M2 Polarization to Alleviate Neuroinflammation after Traumatic Brain Injury.” ACS chemical neuroscience (2025). PMID: 41296614 ↗

    L5OTHERCited in: Etiology and Triggering Factors
  83. [83]

    Escudero C, Vatish M. “Review: The potential role of placental extracellular vesicles in blood-brain barrier disruption and neuroinflammation in preeclampsia.” Placenta (2026). PMID: 40229181 ↗

    L5REVIEW_NARRATIVECited in: Pathophysiology, Special Populations
  84. [84]

    Weiss A, Ding Y. “Beyond Reperfusion: Adjunctive Therapies Targeting Inflammation, Edema, and Blood-Brain Barrier Dysfunction in Ischemic Stroke.” Cerebrovascular diseases (Basel, Switzerland) (2026). PMID: 40609526 ↗

    L5REVIEW_NARRATIVECited in: Pathophysiology
  85. [85]

    Huang R, Gao L, Dai Y et al.. “Olink Proteomics Reveals CCL2 Aggravates Perihematomal Edema After Intracerebral Hemorrhage in High-Altitude Migrants Via CCR2/NF-κB-Mediated Blood-Brain Barrier Disruption.” CNS neuroscience & therapeutics (2026). PMID: 41944579 ↗

    L5OTHERCited in: Pathophysiology
  86. [86]

    Li Y, Yang W, Tang Y et al.. “Aquaporin-4-overexpressing mesenchymal stem cells promote neurological recovery after intracerebral hemorrhage by inhibiting TLR4/NF-κB signaling.” Free radical biology & medicine (2026). PMID: 41380917 ↗

    L5OTHERCited in: Pathophysiology, Medical Management
  87. [87]

    Bevers MB, An J, Yoo A et al.. “Brain Endothelial Soluble ST2 Production and Cerebral Edema in a Rat Model of Ischemic Stroke.” Annals of neurology (2026). PMID: 40833219 ↗

    L5OTHERCited in: Pathophysiology
  88. [88]

    Xue Y, Wan B, Wang Z et al.. “Hydroxychloroquine Prevents High-altitude Cerebral Edema by Inhibiting Endothelial Claudin-5 Autophagic Degradation.” Current neuropharmacology (2026). PMID: 40353467 ↗

    L5OTHERCited in: Pathophysiology, Special Populations
  89. [89]

    Guo P, Siddique R, Qian J et al.. “Apelin-13 Attenuates Blood-Brain Barrier Dysfunction Following Intracerebral Hemorrhage via Targeting the Keap1/Nrf2 Signaling.” CNS neuroscience & therapeutics (2025). PMID: 41459616 ↗

    L5OTHERCited in: Pathophysiology
  90. [90]

    Wu Y, Lv W, Xiong S et al.. “Dalbergia odorifera T.C. Chen leaf extract promotes microglial energy expenditure to phagocytize neutrophils after cerebral ischemia-reperfusion.” Phytomedicine : international journal of phytotherapy and phytopharmacology (2025). PMID: 41253024 ↗

    L5OTHERCited in: Pathophysiology
  91. [91]

    Hou X, Mo X, Zhang X et al.. “Cuproptosis-driven astrocyte reactivity exacerbates experimental cerebral malaria pathogenesis.” Parasites & vectors (2025). PMID: 41214704 ↗

    L5OTHERCited in: Pathophysiology
  92. [92]

    Wu JW, Zhou YT, Wang BX et al.. “Apigenin regulates CCR5/JAK1/STAT1/MMPs signaling to alleviate secondary brain injury after intracerebral hemorrhage and its enhanced delivery via targeted nanoparticles.” Journal of nanobiotechnology (2025). PMID: 41177867 ↗

    L5OTHERCited in: Pathophysiology
  93. [93]

    Michinaga S, Takahashi K, Ogawa Y et al.. “Smoothened Agonist Treatment Mitigates Vasogenic Edema, Neuroinflammation, and Neurological Dysfunction Following Traumatic Brain Injury in Mice.” FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2025). PMID: 41134710 ↗

    L5OTHERCited in: Pathophysiology
  94. [94]

    Yang Y, Chen L, Hou P et al.. “Effects of Irrigation With Normal Saline on Traumatic Brain Injury Combined With Seawater Immersion in Rats.” The Journal of surgical research (2025). PMID: 41073193 ↗

    L5OTHERCited in: Pathophysiology, Medical Management
  95. [95]

    Zhang Y, Wang L, Li D et al.. “Bispecific self-assembled peptides as supra-growth factors for preventing endotheliopathy and improving survival of traumatic brain injury in mice.” Journal of nanobiotechnology (2025). PMID: 41068806 ↗

    L5OTHERCited in: Pathophysiology
  96. [96]

    Wang J, Li L, Xu J et al.. “Neutrophil extracellular traps induce endothelial damage and exacerbate vasospasm in traumatic brain injury.” Theranostics (2025). PMID: 40963908 ↗

    L5OTHERCited in: Pathophysiology
  97. [97]

    Zhang L, Shao Y, Fang Z et al.. “Salvianolic Acid B and Ginsenoside Rg1 Combination Attenuates Cerebral Edema Accompanying Glymphatic Modulation.” Neuroscience bulletin (2025). PMID: 40886214 ↗

    L5OTHERCited in: Pathophysiology
  98. [98]

    Robinson BD, Yeager A, Lomas A et al.. “Quercetin Protects Blood-Brain Barrier Integrity and Maintains Microvascular Permeability Following Traumatic Brain Injury.” Neurocritical care (2025). PMID: 40739078 ↗

    L5OTHERCited in: Pathophysiology
  99. [99]

    Xue YF, Wu YX, Zhang YZ et al.. “Gper1 inhibition exacerbates traumatic brain injury-induced neurological impairments in mice.” Behavioral and brain functions : BBF (2025). PMID: 40605012 ↗

    L5OTHERCited in: Pathophysiology
  100. [100]

    Li Y, Zhou H, Xie J et al.. “Targeting TRPV4 to restore glymphatic system function and alleviate cerebral edema in ischemic stroke.” Brain pathology (Zurich, Switzerland) (2025). PMID: 40481713 ↗

    L5OTHERCited in: Pathophysiology
  101. [101]

    Wang H, Nery ESM, Ardayfio P et al.. “The effect of modified donanemab titration on amyloid-related imaging abnormalities with edema/effusions and amyloid reduction: 18-month results from TRAILBLAZER-ALZ 6.” The journal of prevention of Alzheimer's disease (2025). PMID: 40619285 ↗

    L1bRCTCited in: History and Physical Examination, Landmark Trials and Key Evidence
  102. [102]

    Greer DM, Helbok R, Badjatia N et al.. “Fever Prevention in Patients With Acute Vascular Brain Injury: The INTREPID Randomized Clinical Trial.” JAMA (2024). PMID: 39320879 ↗

    L1bRCTCited in: History and Physical Examination, Supportive Care and Complication Management, Landmark Trials and Key Evidence
  103. [103]

    Yun J, Kim KH, Jung JW et al.. “Effects of blood pressure lowering in patients treated with intravenous thrombolysis before endovascular thrombectomy.” International journal of stroke : official journal of the International Stroke Society (2025). PMID: 39819210 ↗

    L2bTRIAL_NONRANDOMCited in: History and Physical Examination, Prognosis and Long-term Outcomes
  104. [104]

    Łagowski W, Grodzka O, Domitrz I. “Atypical neurological symptoms at high altitude: a systematic literature review.” Travel medicine and infectious disease (2025). PMID: 40379194 ↗

    L2aSR_OBSCited in: History and Physical Examination, Special Populations
  105. [105]

    Tanti MJ, Nevitt S, Yeo M et al.. “Oedema as a prognostic factor for seizures in meningioma - a systematic review and meta-analysis.” Neurosurgical review (2025). PMID: 39969698 ↗

    L2aSR_OBSCited in: History and Physical Examination, Supportive Care and Complication Management, Prognosis and Long-term Outcomes
  106. [106]

    Song X, Wang Y, Guo W et al.. “Time-varying association between blood pressure and malignant brain edema after large hemispheric infarction: a prospective cohort study.” Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2025). PMID: 40155579 ↗

    L2bCOHORTCited in: History and Physical Examination
  107. [107]

    Evans AS, Singh S, Joshi C et al.. “Examining Clinical Features and Severe Neurologic Disease of Parechovirus Infection in Young Infants: A Multistate Cohort Study.” Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024). PMID: 39093815 ↗

    L2bCOHORTCited in: History and Physical Examination, Supportive Care and Complication Management
  108. [108]

    Rajendran G, Mahalingam S, Ramkumar A et al.. “Diagnostic Accuracy of Optic Nerve Sheath Diameter Using Ultrasonography for Raised Intracranial Pressure in Pediatric Patients - A Systematic Review and Meta-Analysis.” World neurosurgery (2024). PMID: 39142382 ↗

    L2aSR_OBSCited in: History and Physical Examination
  109. [109]

    Capece G, Caumo L, Volta S et al.. “Wernicke Encephalopathy Complicating a Distinctive POLG Phenotype With MNGIE-Like Features.” European journal of neurology (2026). PMID: 41841518 ↗

    L4CASE_REPORTCited in: History and Physical Examination
  110. [110]

    Gibson AW, Elser H, Rosso M et al.. “Ischemic stroke associated with amyloid-related imaging abnormalities in a patient treated with lecanemab.” Alzheimer's & dementia : the journal of the Alzheimer's Association (2024). PMID: 39215494 ↗

    L4CASE_REPORTCited in: History and Physical Examination, Supportive Care and Complication Management
  111. [111]

    Rohm Z, Goldman MD, Riley C et al.. “A 73-Year-Old Woman With Confusion, Visual Field Disturbances, and Edematous White Matter Lesions: From the National Multiple Sclerosis Society Case Conference Proceedings.” Neurology(R) neuroimmunology & neuroinflammation (2024). PMID: 39141887 ↗

    L4CASE_REPORTCited in: History and Physical Examination
  112. [112]

    Diorio C, Hernandez-Miyares L, Espinoza DA et al.. “Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents.” Blood (2024). PMID: 38905637 ↗

    L4CASE_REPORTCited in: History and Physical Examination
  113. [113]

    Avorio F, Russelli G, Alduino R et al.. “Early-Onset Seizures After Orthotopic Liver Transplantation: A Single-Center Retrospective Study.” Transplantation proceedings (2025). PMID: 39824671 ↗

    L2bCOHORTCited in: History and Physical Examination, Supportive Care and Complication Management
  114. [114]

    Macháček M, Bébarová M. “Triggers of highly lethal seizures induced by novel stimulants: A systematic review focused on synthetic cathinones and phenethylamines.” Neurotoxicology (2026). PMID: 41544778 ↗

    L2aSR_OBSCited in: History and Physical Examination, Supportive Care and Complication Management
  115. [115]

    You L, Hu M, Li J et al.. “The mechanism of electroacupuncture treatment for post-stroke spasticity: A systematic review and Meta-analysis.” Behavioural brain research (2026). PMID: 41101592 ↗

    L2aSR_OBSCited in: History and Physical Examination, Medical Management
  116. [116]

    Nail J, Herendeen J. “Postoperative Considerations Following Decompressive Hemicraniectomy.” Neurosurgery clinics of North America (2026). PMID: 41967895 ↗

    L5REVIEW_NARRATIVECited in: History and Physical Examination, Surgical Management
  117. [117]

    Kang K, Ji Z, Hao Y et al.. “Decreased 24-hour Parasympathetic Activity following Intracerebral Hemorrhage: A Key Factor Correlated with Adverse Perihematomal Edema and Poor Functional Outcomes.” CNS neuroscience & therapeutics (2026). PMID: 41499465 ↗

    L5OTHERCited in: History and Physical Examination
  118. [118]

    Lim MS, AlBaram R, Leonard A et al.. “Electrode Tract Oedema in Stereo-Electroencephalography.” Stereotactic and functional neurosurgery (2026). PMID: 40675143 ↗

    L5OTHERCited in: History and Physical Examination, Surgical Management
  119. [119]

    Wu T, Wang K, Sun B et al.. “An Implantable System Design Based on Neuromorphic Memristor for Post-Craniotomy Intracranial Pressure Monitoring.” ACS applied materials & interfaces (2025). PMID: 41032885 ↗

    L5OTHERCited in: History and Physical Examination, Diagnosis and Workup, Surgical Management
  120. [120]

    Nimmo A, Younsi A. “The Relationship Between Inflammation and the Development of Cerebral Ischaemia and Hypoxia in Traumatic Brain Injury-A Narrative Review.” International journal of molecular sciences (2025). PMID: 40869387 ↗

    L5REVIEW_NARRATIVECited in: History and Physical Examination
  121. [121]

    McClelland AC, Ellis CA, Kuo E et al.. “Atypical Edema in Posterior Reversible Encephalopathy Syndrome: Clinical Associations and Outcome.” Journal of neuroimaging : official journal of the American Society of Neuroimaging (2025). PMID: 40824279 ↗

    L5OTHERCited in: History and Physical Examination, Differential Diagnosis
  122. [122]

    Pansell J, Thomsson T, Eng E et al.. “Optic Nerve Sheath Diameter: Which Axis Should Be Measured?” Journal of neuroimaging : official journal of the American Society of Neuroimaging (2025). PMID: 40754891 ↗

    L5OTHERCited in: History and Physical Examination
  123. [123]

    Wang Z, Kulpanowski AM, Copen WA et al.. “Automated detection of severe cerebral edema using explainable deep transfer learning after hypoxic ischemic brain injury.” Resuscitation (2025). PMID: 40414341 ↗

    L5OTHERCited in: History and Physical Examination
  124. [124]

    Trovato FM, Khan PA, Calvert S et al.. “Cerebral Edema in Acute Liver Failure: Insights From Autopsy.” Liver international : official journal of the International Association for the Study of the Liver (2025). PMID: 40265956 ↗

    L5OTHERCited in: History and Physical Examination
  125. [125]

    Li Z, Zhang J, Zhang X et al.. “Oxygen metabolism abnormalities and high-altitude cerebral edema.” Frontiers in immunology (2025). PMID: 40176814 ↗

    L5REVIEW_NARRATIVECited in: History and Physical Examination, Special Populations
  126. [126]

    Berra LV, Rubiano A, Cedrone G et al.. “Comparison of brain volume increase in patients with intracranial hypertension after decompressive craniectomy and expansion craniotomy.” Neurosurgical review (2025). PMID: 40113631 ↗

    L5OTHERCited in: History and Physical Examination, Surgical Management
  127. [127]

    Chen DF, Farrque M, Karakis I et al.. “Continuous Electroencephalography in Acute Liver Failure: Findings and Prognostic Value.” Neurocritical care (2025). PMID: 39920548 ↗

    L5OTHERCited in: History and Physical Examination, Supportive Care and Complication Management
  128. [128]

    Li H, Wang Y, Li L et al.. “Clinical characteristics, imaging, treatment, and prognosis of dural arteriovenous fistula presented with Parkinsonism- a systematic review.” Neurosurgical review (2025). PMID: 40875094 ↗

    L2aSR_OBSCited in: Diagnosis and Workup, Prognosis and Long-term Outcomes
  129. [129]

    Polymeris AA, Lioutas VA, Incontri D et al.. “Evolution of Perihematomal Edema Mean Hounsfield Unit and Its Association with Clinical Outcome in Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial.” Neurocritical care (2025). PMID: 40789806 ↗

    L1bRCTCited in: Diagnosis and Workup, Prognosis and Long-term Outcomes, Landmark Trials and Key Evidence
  130. [130]

    Wang L, Wu G, Cao A et al.. “Effect of APOE ε4 Gene on Perihematomal Edema in Intracerebral Hemorrhage: A Prospective Study.” Neurocritical care (2025). PMID: 40764846 ↗

    L2bCOHORTCited in: Diagnosis and Workup
  131. [131]

    Cardoso FS, Lee WM, Karvellas CJ. “Brain CT Scan Diagnostic and Prognostic Value in Patients With Acute Liver Failure and Cerebral Edema: A Multicenter Cohort Study.” Critical care explorations (2025). PMID: 40232229 ↗

    L2bCOHORTCited in: Diagnosis and Workup, Prognosis and Long-term Outcomes
  132. [132]

    Chong ST, Yang JY, Lin CP. “Understanding tractography in edematous brain regions: challenges and solutions.” Brain structure & function (2025). PMID: 40343560 ↗

    L5REVIEW_NARRATIVECited in: Diagnosis and Workup
  133. [133]

    Johnson C, Miller G, Shah S et al.. “Unveiling patterns of peri-lead edema after deep brain stimulation: a retrospective review of clinical and demographic factors.” Neuroradiology (2025). PMID: 40198366 ↗

    L5REVIEW_NARRATIVECited in: Diagnosis and Workup
  134. [134]

    Guo Y, Hao H, Sun Y. “Generalized cortical encephalitis in autoimmune GFAP astrocytopathy.” Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2025). PMID: 40588684 ↗

    L4CASE_REPORTCited in: Diagnosis and Workup
  135. [135]

    Greene JP, Sigman EJ, Podell J et al.. “The Role of Neuroimaging in Traumatic Brain and Spinal Cord Injury.” Seminars in neurology (2025). PMID: 41119962 ↗

    L5REVIEW_NARRATIVECited in: Diagnosis and Workup
  136. [136]

    Jiang X, Guo H, Xiao W et al.. “Advancements in Non-Invasive Intracranial Pressure Monitoring via Optic Nerve Sheath Diameter Measurement.” Medical science monitor : international medical journal of experimental and clinical research (2025). PMID: 40413578 ↗

    L5REVIEW_NARRATIVECited in: Diagnosis and Workup
  137. [137]

    Zou M, Li J, Yao H et al.. “Toxic encephalopathy due to mercury: A rare case report and literature review.” Medicine (2025). PMID: 40958342 ↗

    L4CASE_REPORTCited in: Diagnosis and Workup
  138. [138]

    Jlailati A, Al Sbenaty G, Boali O et al.. “Radiation-induced temporal lobe necrosis in a nasopharyngeal cancer patient after external beam radiotherapy: a case report and review of literature.” Journal of medical case reports (2025). PMID: 40652209 ↗

    L4CASE_REPORTCited in: Diagnosis and Workup
  139. [139]

    Yu Q, Kothe K, Kwiatek RA et al.. “Evidence of White Matter Neuroinflammation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Diffusion-Based Neuroinflammation Imaging Study.” Human brain mapping (2026). PMID: 41834684 ↗

    L5OTHERCited in: Diagnosis and Workup
  140. [140]

    Wilting FNH, Douwes JPJ, Patel A et al.. “Deep learning-based automated segmentation of intracerebral haemorrhage, intraventricular haemorrhage and perihaematomal oedema on non-contrast CT.” European stroke journal (2026). PMID: 41792040 ↗

    L5OTHERCited in: Diagnosis and Workup
  141. [141]

    Basaran AE, Braune M, Barrantes-Freer A et al.. “FOXC1 expression and radiological predictors of peritumoral brain edema in meningiomas.” Journal of neuro-oncology (2026). PMID: 41632362 ↗

    L5OTHERCited in: Diagnosis and Workup, Prognosis and Long-term Outcomes
  142. [142]

    Remore LG, Fiore G, Pirola E et al.. “Perilead Edema in Deep Brain Stimulation: Long-Term Outcomes and Etiologic Correlates.” Neuromodulation : journal of the International Neuromodulation Society (2026). PMID: 41165632 ↗

    L5OTHERCited in: Diagnosis and Workup, Medical Management
  143. [143]

    Ding N, Xiang B, Jiang H et al.. “OCT-PAM dual-mode imaging to evaluate early ischemic stroke in rats.” Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2026). PMID: 40832974 ↗

    L5OTHERCited in: Diagnosis and Workup
  144. [144]

    Carroll D, Darling A, Shrum A et al.. “A Case of Pediatric Opioid Use-Associated Neurotoxicity with Cerebellar Edema (POUNCE) Syndrome Requiring Suboccipital Craniectomy with a Favorable Neurological Outcome.” The Journal of emergency medicine (2026). PMID: 41270319 ↗

    L4CASE_REPORTCited in: Diagnosis and Workup
  145. [145]

    Leon G, Halgas B, Sullivan S et al.. “Frontal Lobe Thermal Injury Mimicking Cerebritis on Imaging.” Journal of burn care & research : official publication of the American Burn Association (2026). PMID: 41172149 ↗

    L4CASE_REPORTCited in: Diagnosis and Workup, Differential Diagnosis
  146. [146]

    Nagels N, Ghesquière M, Claeys T et al.. “Pseudohypoxic brain swelling in a case of acute craniospinal hypotension.” Acta neurologica Belgica (2026). PMID: 41138028 ↗

    L4CASE_REPORTCited in: Diagnosis and Workup
  147. [147]

    Garcia-Garcia S, Laajava J, Takala J et al.. “MRI radiomic signature predicts peritumoral brain edema resolution following meningioma surgery.” Acta neurochirurgica (2025). PMID: 41339597 ↗

    L5OTHERCited in: Diagnosis and Workup
  148. [148]

    He J, Cheng Y, Pan Y et al.. “Comparison of multiple tractography pipelines for corticospinal tract reconstruction applied to brain tumor patients.” Neuroradiology (2025). PMID: 41160112 ↗

    L5OTHERCited in: Diagnosis and Workup
  149. [149]

    El-Abtah ME, Murayi R, Lee J et al.. “Radiological Differentiation Between Intracranial Meningioma and Solitary Fibrous Tumor/Hemangiopericytoma: A Systematic Literature Review.” World neurosurgery (2023). PMID: 36403933 ↗

    L2aSR_OBSCited in: Differential Diagnosis
  150. [150]

    Chaudhuri J, Basu S, Roy MK et al.. “Posterior Reversible Leucoencephalopathy Syndrome: Case Series, Comments, and Diagnostic Dilemma.” Current neurology and neuroscience reports (2023). PMID: 37378723 ↗

    L4CASE_REPORTCited in: Differential Diagnosis, Supportive Care and Complication Management
  151. [151]

    Zouari R, Saeid MZ, Marzouk M et al.. “Diffuse cerebral edema with leukoencephalopathy revealing systemic lupus erythematosus: A case report and review of literature.” Lupus (2023). PMID: 37887528 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  152. [152]

    Perillo T, Paolella C, Perrotta G et al.. “Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings.” La Radiologia medica (2022). PMID: 35932443 ↗

    L5REVIEW_NARRATIVECited in: Differential Diagnosis
  153. [153]

    Trivedi S, Chakravarty A. “Neurological Complications of Malaria.” Current neurology and neuroscience reports (2022). PMID: 35699901 ↗

    L5REVIEW_NARRATIVECited in: Differential Diagnosis
  154. [154]

    Guarnizo A, Albreiki D, Cruz JP et al.. “Papilledema: A Review of the Pathophysiology, Imaging Findings, and Mimics.” Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes (2022). PMID: 35044276 ↗

    L5REVIEW_NARRATIVECited in: Differential Diagnosis
  155. [155]

    Fishel Bartal M, Sibai BM. “Eclampsia in the 21st century.” American journal of obstetrics and gynecology (2022). PMID: 32980358 ↗

    L5REVIEW_NARRATIVECited in: Differential Diagnosis, Supportive Care and Complication Management
  156. [156]

    Yang B, Guo L, Yang X et al.. “The pathogenesis and treatment of posterior reversible encephalopathy syndrome after neuromyelitis optica spectrum disorder: a case report and literature review.” BMC neurology (2022). PMID: 36539740 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  157. [157]

    Gewirtz AN, Gao V, Parauda SC et al.. “Posterior Reversible Encephalopathy Syndrome.” Current pain and headache reports (2021). PMID: 33630183 ↗

    L5REVIEW_NARRATIVECited in: Differential Diagnosis, Supportive Care and Complication Management
  158. [158]

    Pujari SS, Kulkarni RV, Ojha P et al.. “Acute haemorrhagic leukoencephalitis (AHLE) - our experience and a short review.” Journal of neuroimmunology (2021). PMID: 34739912 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  159. [159]

    Majethia P, Mishra S, Rao LP et al.. “NAD(P)HX dehydratase (NAXD) deficiency due to a novel biallelic missense variant and review of literature.” European journal of medical genetics (2021). PMID: 34161859 ↗

    L4CASE_REPORTCited in: Differential Diagnosis, Supportive Care and Complication Management
  160. [160]

    Hu S, Yan W, Zhang H et al.. “Acute necrotizing encephalopathy caused by bacterial infection.” BMC infectious diseases (2024). PMID: 39370524 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  161. [161]

    Koenigsberg RA, Ross L, Timmerman J et al.. “Case of pediatric cerebellar, hippocampal, and basal nuclei transient edema with restricted diffusion (CHANTER) syndrome in a 2-year-old girl.” Pediatric radiology (2024). PMID: 38630282 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  162. [162]

    Fikse DJ, Grenz PM, Wheatley SM et al.. “Posterior reversible encephalopathy syndrome associated with Henoch Schonlein Purpura in a pediatric patient.” The American journal of emergency medicine (2021). PMID: 33097321 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  163. [163]

    Theisen A, Bose P, Knight C et al.. “Leukoencephalopathy and cerebral edema as the presenting manifestations of SLE in an ANA-negative adolescent female: a case report and review of literature.” Pediatric rheumatology online journal (2020). PMID: 32660518 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  164. [164]

    Dixon L, Varley J, Gontsarova A et al.. “COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.” Neurology(R) neuroimmunology & neuroinflammation (2020). PMID: 32457227 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  165. [165]

    Chionatos RA, Lerner DP, Burns JD et al.. “Alcohol-related posterior reversible encephalopathy syndrome: a case report of a patient managed with a benzodiazepine-sparing regimen for alcohol withdrawal.” Neurocase (2023). PMID: 38700146 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  166. [166]

    Parasher A, Jhamb R. “Posterior reversible encephalopathy syndrome (PRES): presentation, diagnosis and treatment.” Postgraduate medical journal (2020). PMID: 32467104 ↗

    L5REVIEW_NARRATIVECited in: Differential Diagnosis
  167. [167]

    Panagopoulos D, Themistocleous M, Apostolopoulou K. “Edema of the Floor of the Fourth Ventricle Accompanying Shunt Malfunction and Disappearance of It After Shunt Repair: Case Report and Literature Review.” The American journal of case reports (2019). PMID: 31874952 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  168. [168]

    Brao A, Sánchez Á, Rodríguez I et al.. “Gene therapy rescues brain edema and motor function in a mouse model of megalencephalic leukoencephalopathy with subcortical cysts.” Molecular therapy : the journal of the American Society of Gene Therapy (2025). PMID: 40051162 ↗

    L5OTHERCited in: Differential Diagnosis
  169. [169]

    Demirel E, Dilek O. “Utilizing Radiomics of Peri-Lesional Edema in T2-FLAIR Subtraction Digital Images to Distinguish High-Grade Glial Tumors From Brain Metastasis.” Journal of magnetic resonance imaging : JMRI (2025). PMID: 39254002 ↗

    L5OTHERCited in: Differential Diagnosis
  170. [170]

    Dall'Asta A, Melito C, Petrolini C et al.. “First Intrapartum Sonographic Diagnosis of Fetal Hypoxic-Ischemic Encephalopathy.” Fetal diagnosis and therapy (2025). PMID: 39874954 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  171. [171]

    Lyu TJ, Wang J, Zhao F et al.. “CCL4 as a potential serum factor in differential diagnosis of central nervous system inflammatory diseases and gliomas.” Frontiers in immunology (2024). PMID: 39364412 ↗

    L5OTHERCited in: Differential Diagnosis
  172. [172]

    Nada MG, Libda YI, Gohary MM et al.. “Pediatric posterior reversible encephalopathy syndrome: Can MR imaging features predict outcomes in non-oncologic patients?” European journal of radiology (2024). PMID: 38007856 ↗

    L5OTHERCited in: Differential Diagnosis
  173. [173]

    Czerminski J, Khatri S, Rao B. “Amyloid related imaging abnormalities in the emergency setting.” Emergency radiology (2024). PMID: 39331307 ↗

    L4CASE_REPORTCited in: Differential Diagnosis
  174. [174]

    Passchier EMJ, Kerst S, Brouwers E et al.. “Aquaporin-4 and GPRC5B: old and new players in controlling brain oedema.” Brain : a journal of neurology (2023). PMID: 37143309 ↗

    L5OTHERCited in: Differential Diagnosis
  175. [175]

    Ajmi H, Brahim J, Mabrouk S et al.. “Clinical and radiological findings of posterior reversible encephalopathy syndrome in children: About 16 children hospitalized in the pediatric department of a Tunisian tertiary care hospital.” European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society (2023). PMID: 36871341 ↗

    L5OTHERCited in: Differential Diagnosis
  176. [176]

    Akcil EF, Dilmen OK, Tunali Y. “Hypertonic saline versus mannitol for brain relaxation in supratentorial tumor surgery: a prospective randomized trial.” Brazilian journal of anesthesiology (Elsevier) (2025). PMID: 40967382 ↗

    L1bRCTCited in: Medical Management, Surgical Management
  177. [177]

    Shi Q, Han S, Li X et al.. “Oxygen Therapy for Intracranial Hemorrhage.” CNS neuroscience & therapeutics (2026). PMID: 41735793 ↗

    L2aSR_OBSCited in: Medical Management
  178. [178]

    Akhavan-Sigari A, Sbaih O, Hori YS et al.. “Perilesional Edema as a Predictor of Local Failure in Metastatic Brain Lesions Treated With Stereotactic Radiosurgery: A Systematic Review and Meta-Analysis.” International journal of radiation oncology, biology, physics (2026). PMID: 40588068 ↗

    L2aSR_OBSCited in: Medical Management, Surgical Management, Prognosis and Long-term Outcomes
  179. [179]

    Totapally B, Barhen A, De Angulo G. “Hemorrhagic complications and outcomes of children with acute promyelocytic leukemia at initial hospital admission: a multicenter cohort study.” Pediatric hematology and oncology (2025). PMID: 40384474 ↗

    L2bCOHORTCited in: Medical Management
  180. [180]

    Tenenbein M. “We need a standardized North American acetylcysteine dosing regimen for the treatment of paracetamol (acetaminophen) poisoning.” Clinical toxicology (Philadelphia, Pa.) (2026). PMID: 41608767 ↗

    L5OTHERCited in: Medical Management
  181. [181]

    Schutzman LM, Taylor SL, Fiehn O et al.. “Metabolomic Assessment of Low- Versus High-Volume Resuscitation in a Combined Porcine Model of Severe Burn and Traumatic Brain Injury.” Shock (Augusta, Ga.) (2026). PMID: 40997256 ↗

    L5OTHERCited in: Medical Management
  182. [182]

    Lieschke F, Zheng Y, Lok J et al.. “Dual antiplatelet therapy increases intracerebral hemorrhage and edema after controlled cortical impact and can be partially encountered by 12/15-lipoxygenase inhibition.” Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2026). PMID: 40947949 ↗

    L5OTHERCited in: Medical Management
  183. [183]

    West E, Patwardhan UM, Calvo R et al.. “Under pressure: Identifying factors for pediatric patients with severe traumatic brain injury who benefit from external ventricular drainage.” Journal of pediatric surgery (2026). PMID: 40803408 ↗

    L5OTHERCited in: Medical Management
  184. [184]

    Tsuiki N, Aihara T, Hayakawa I et al.. “Child neurology: Early neuroprotective and immunomodulatory intervention in acute shock with encephalopathy and multiorgan failure: Cytokine-storm encephalopathy-case report.” Brain & development (2026). PMID: 41679242 ↗

    L4CASE_REPORTCited in: Medical Management
  185. [185]

    Alavi Darazam I, Isazadeh M, Zaresharifi S et al.. “Infection With Mycobacterium chelonae Following Autologous Facial Fat Grafting: A Case Report and Review of Literature.” Journal of cosmetic dermatology (2026). PMID: 41449970 ↗

    L4CASE_REPORTCited in: Medical Management
  186. [186]

    Tian B, Chen M, Cheng J et al.. “Factors and outcomes associated with acute kidney injury in brain tumor resection patients: insights from a large US database (2010-2019).” Renal failure (2025). PMID: 41285121 ↗

    L5OTHERCited in: Medical Management
  187. [187]

    Liu CC, Chen IW, Liu PH et al.. “Efficacy of propofol-based anesthesia against risk of brain swelling during craniotomy: A meta-analysis of randomized controlled studies.” Journal of clinical anesthesia (2024). PMID: 37883902 ↗

    L2aSR_OBSCited in: Surgical Management
  188. [188]

    Laajava J, Niemelä M, Korja M. “Peritumoral edema resolves infrequently in surgically treated patients with intracranial meningioma- a retrospective study of 279 meningioma patients.” Journal of neuro-oncology (2025). PMID: 40048039 ↗

    L2bCOHORTCited in: Surgical Management
  189. [189]

    Tsai CY, Kuo KL, Wu CH et al.. “An Analysis of Emergency Surgical Outcomes for Pediatric Traumatic Brain Injury: A Ten-Year Single-Institute Retrospective Study in Taiwan.” Medicina (Kaunas, Lithuania) (2024). PMID: 39336560 ↗

    L2bCOHORTCited in: Surgical Management
  190. [190]

    Taussig D, Petrescu AM, Herbrecht A et al.. “Vasogenic oedema during stereoelectroencephalography: intracranial pattern and late-onset clinical repercussion.” Journal of neurology (2024). PMID: 39046522 ↗

    L4CASE_REPORTCited in: Surgical Management
  191. [191]

    Frost ED, Pruthi A, Tonetti D et al.. “Perihematomal Edema Characteristics After Minimally Invasive Surgery in Intracerebral Hemorrhage.” Critical care explorations (2025). PMID: 41416863 ↗

    L5OTHERCited in: Surgical Management
  192. [192]

    Ramponi A, Di Cristofori A, Graziano F et al.. “CT hyperdensities after recanalization for anterior circulation large vessels occlusion: a predictor for malignant brain edema after ischemic stroke?” Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2025). PMID: 40954437 ↗

    L5OTHERCited in: Surgical Management
  193. [193]

    Sconzo D, Ramirez-Velandia F, Enriquez-Marulanda A et al.. “Reversible edema after radiosurgery for arteriovenous malformations (AVMs): Inflow and outflow imbalance.” Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2025). PMID: 40889337 ↗

    L5OTHERCited in: Surgical Management
  194. [194]

    Tu J, Shen C, Liu J et al.. “Detection of Microscopic Glioblastoma Infiltration in Peritumoral Edema Using Interactive Deep Learning With DTI Biomarkers: Testing via Stereotactic Biopsy.” Journal of magnetic resonance imaging : JMRI (2025). PMID: 40888617 ↗

    L5OTHERCited in: Surgical Management
  195. [195]

    Sasame J, Shuto T, Matsunaga S et al.. “Effectiveness of Gamma Knife radiosurgery for recurrent glioblastoma: a 10-year retrospective analysis.” Neurosurgical review (2025). PMID: 40653575 ↗

    L5OTHERCited in: Surgical Management
  196. [196]

    Fukami S, Nagai K, Nakajima N et al.. “Usefulness and pitfalls of neuroendoscopic tumor biopsy for intracranial malignant lymphoma.” Neurosurgical review (2025). PMID: 40439772 ↗

    L5OTHERCited in: Surgical Management
  197. [197]

    Upadhyay R, Elguindy ANM, Salts L et al.. “Boswellia Serrata for Cerebral Radiation Necrosis After Radiosurgery for Brain Metastases.” International journal of radiation oncology, biology, physics (2025). PMID: 39993542 ↗

    L5OTHERCited in: Surgical Management
  198. [198]

    Krafft PR, Tafel I, Khanna A et al.. “Dynamic Craniotomy With Khanna NuCrani Plates as an Alternative to Craniotomy With Fixed Plates in Traumatic Brain Injury.” Neurosurgery (2025). PMID: 39495022 ↗

    L5OTHERCited in: Surgical Management
  199. [199]

    Cui M, Tang X, Xiong W et al.. “Feasibility Study of Endoscopic Surgery for Spontaneous Intracerebral Hemorrhage with Large Hematoma: a Comparison with Craniotomy Using Propensity Score Matching Analysis.” Neurocritical care (2025). PMID: 39192100 ↗

    L5OTHERCited in: Surgical Management
  200. [200]

    Ong CJ, Huang Q, Kim ISY et al.. “Association of Dynamic Trajectories of Time-Series Data and Life-Threatening Mass Effect in Large Middle Cerebral Artery Stroke.” Neurocritical care (2025). PMID: 38955931 ↗

    L5OTHERCited in: Surgical Management
  201. [201]

    Shields LBE, Chariker M, Sieg EP et al.. “Vacuum-assisted closure of the scalp flap following malignant cerebral edema during craniotomy: pediatric case presentations and review of the literature.” Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2025). PMID: 41165862 ↗

    L4CASE_REPORTCited in: Surgical Management
  202. [202]

    Tuzi S, Kranawetter B, Mielke D et al.. “Systematic assessment of early brain injury severity at admission with aneurysmal subarachnoid hemorrhage.” Neurosurgical review (2024). PMID: 39514015 ↗

    L5OTHERCited in: Surgical Management
  203. [203]

    Yavorska M, Tomaciello M, Sciurti A et al.. “Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.” Journal of neuro-oncology (2024). PMID: 39259411 ↗

    L5OTHERCited in: Surgical Management
  204. [204]

    Li J, Sun W, Hu S et al.. “The Implication of Photodynamic Therapy Applied to the Level of Tumor Resection on Postoperative Cerebral Edema and Intracranial Pressure Changes in Gliomas.” Lasers in surgery and medicine (2024). PMID: 39256928 ↗

    L5OTHERCited in: Surgical Management
  205. [205]

    Aboukais R, Devalckeneer A, Boussemart P et al.. “Giant unruptured middle cerebral artery aneurysm revealed by intracranial hypertension: is a systematic decompressive hemicraniotomy mandatory?” Neurosurgical review (2024). PMID: 39117892 ↗

    L5OTHERCited in: Surgical Management
  206. [206]

    Tuzi S, Kranawetter B, Moerer O et al.. “Influence of cerebrospinal fluid drainage in the first days after aneurysm rupture on the severity of early brain injury following aneurysmal subarachnoid hemorrhage.” Acta neurochirurgica (2024). PMID: 38805034 ↗

    L5OTHERCited in: Surgical Management
  207. [207]

    Ellens NR, Albert GP, Bender MT et al.. “Trends and predictors of decompressive craniectomy in acute ischemic stroke, 2011-2020.” Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2024). PMID: 38583545 ↗

    L5OTHERCited in: Surgical Management
  208. [208]

    Guo W, Xu M, Song X et al.. “Association of Serum Macrophage Migration Inhibitory Factor with 3-Month Poor Outcome and Malignant Cerebral Edema in Patients with Large Hemispheric Infarction.” Neurocritical care (2024). PMID: 38561586 ↗

    L5OTHERCited in: Surgical Management
  209. [209]

    Özen Olcay H, Emektar E, Çorbacıoğlu ŞK et al.. “A retrospective study of CT scan utilization in the emergency department for patients presenting with seizures.” The American journal of emergency medicine (2024). PMID: 38583342 ↗

    L2bCOHORTCited in: Supportive Care and Complication Management
  210. [210]

    Blank SP, Blank RM, Campbell L. “What Is the Optimal Speed of correction of the Hyperosmolar Hyperglycemic State in Diabetic Ketoacidosis? An Observational Cohort Study of U.S. Intensive Care Patients.” Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists (2022). PMID: 35688365 ↗

    L2bCOHORTCited in: Supportive Care and Complication Management
  211. [211]

    Park S. “Emergent Management of Spontaneous Subarachnoid Hemorrhage.” Continuum (Minneapolis, Minn.) (2024). PMID: 38830067 ↗

    L4CASE_REPORTCited in: Supportive Care and Complication Management, Guidelines and Resources
  212. [212]

    Leslie-Mazwi TM. “Neurocritical Care for Patients With Ischemic Stroke.” Continuum (Minneapolis, Minn.) (2024). PMID: 38830065 ↗

    L4CASE_REPORTCited in: Supportive Care and Complication Management
  213. [213]

    Rondon-Berrios H. “Diagnostic and Therapeutic Strategies to Severe Hyponatremia in the Intensive Care Unit.” Journal of intensive care medicine (2024). PMID: 37822230 ↗

    L5REVIEW_NARRATIVECited in: Supportive Care and Complication Management
  214. [214]

    Qaryouti D, Greene-Chandos D. “Neurocritical Care Aspects of Ischemic Stroke Management.” Critical care clinics (2023). PMID: 36333037 ↗

    L5REVIEW_NARRATIVECited in: Supportive Care and Complication Management
  215. [215]

    Youssef G, Wen PY. “Medical and Neurological Management of Brain Tumor Complications.” Current neurology and neuroscience reports (2021). PMID: 34545509 ↗

    L5REVIEW_NARRATIVECited in: Supportive Care and Complication Management
  216. [216]

    Hernandez S, Kittelty K, Hodgson CL. “Rehabilitating the neurological patient in the ICU: what is important?” Current opinion in critical care (2021). PMID: 33395083 ↗

    L5REVIEW_NARRATIVECited in: Supportive Care and Complication Management
  217. [217]

    Mahendra V, Clark SL, Suresh MS. “Neuropathophysiology of preeclampsia and eclampsia: A review of cerebral hemodynamic principles in hypertensive disorders of pregnancy.” Pregnancy hypertension (2021). PMID: 33310389 ↗

    L5REVIEW_NARRATIVECited in: Supportive Care and Complication Management
  218. [218]

    Tlais D, Fetzko S, Gulati N et al.. “A Toddler With New Seizures, Progressive White Matter Lesions, and Multifocal Microhemorrhages.” Pediatrics (2022). PMID: 36325804 ↗

    L4CASE_REPORTCited in: Supportive Care and Complication Management
  219. [219]

    Gong P, Karakas C, Morgan B. “Child Neurology: Hemiconvulsion-Hemiplegia-Epilepsy Syndrome in the Setting of COVID-19 Infection and Multisystem Inflammatory Syndrome.” Neurology (2022). PMID: 36008144 ↗

    L4CASE_REPORTCited in: Supportive Care and Complication Management
  220. [220]

    Fragoso DC, Marx C, Dutra BG et al.. “COVID-19 as a Cause of Acute Neonatal Encephalitis and Cerebral Cytotoxic Edema.” The Pediatric infectious disease journal (2021). PMID: 33902082 ↗

    L4CASE_REPORTCited in: Supportive Care and Complication Management
  221. [221]

    Walabh P, Karvellas CJ. “What's new in the critical care management of acute liver failure: a focus on global accessibility.” Expert review of gastroenterology & hepatology (2025). PMID: 40883866 ↗

    L5REVIEW_NARRATIVECited in: Supportive Care and Complication Management
  222. [222]

    V Bonm A, Taylor LP. “Management of Neurologic Complications in Patients with Brain and Spine Tumors.” Seminars in neurology (2024). PMID: 38176424 ↗

    L5REVIEW_NARRATIVECited in: Supportive Care and Complication Management
  223. [223]

    Ramos AP, Burneo JG. “Seizures and epilepsy associated with central nervous system tuberculosis.” Seizure (2023). PMID: 36963243 ↗

    L5REVIEW_NARRATIVECited in: Supportive Care and Complication Management
  224. [224]

    Aboul-Nour H, Jumah A, Abdulla H et al.. “Neurological monitoring in ECMO patients: current state of practice, challenges and lessons.” Acta neurologica Belgica (2023). PMID: 36701079 ↗

    L5REVIEW_NARRATIVECited in: Supportive Care and Complication Management
  225. [225]

    Greige T, Tao BS, Dangayach NS et al.. “Cerebral Edema Monitoring and Management Strategies: Results from an International Practice Survey.” Neurocritical care (2025). PMID: 39085504 ↗

    L5OTHERCited in: Supportive Care and Complication Management, Guidelines and Resources
  226. [226]

    Lin R, Luo R, Yu X et al.. “Depleting parenchymal border macrophages alleviates cerebral edema and neuroinflammation following status epilepticus.” Journal of translational medicine (2024). PMID: 39623451 ↗

    L5OTHERCited in: Supportive Care and Complication Management
  227. [227]

    Teske N, Teske NC, Greve T et al.. “Perifocal edema is a risk factor for preoperative seizures in patients with meningioma WHO grade 2 and 3.” Acta neurochirurgica (2024). PMID: 38581569 ↗

    L5OTHERCited in: Supportive Care and Complication Management
  228. [228]

    Nie X, Liu J, Yan B et al.. “Cerebral Edema Progression and Outcomes in Large Infarct Patients Undergoing Endovascular Thrombectomy.” Annals of neurology (2025). PMID: 40065687 ↗

    L1bRCTCited in: Prognosis and Long-term Outcomes, Landmark Trials and Key Evidence
  229. [229]

    Sheth KN, Albers GW, Saver JL et al.. “Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.” The Lancet. Neurology (2024). PMID: 39577921 ↗

    L1bRCTCited in: Prognosis and Long-term Outcomes, Landmark Trials and Key Evidence
  230. [230]

    Réen L, Radman A, Visse E et al.. “Outcome in adult patients with severe TBI, using a management protocol allowing a cerebral perfusion pressure ≤ 60 mmHg - a retrospective study over 10 years.” Acta neurochirurgica (2025). PMID: 41128918 ↗

    L2bCOHORTCited in: Prognosis and Long-term Outcomes
  231. [231]

    Weiss SA, Djureinovic D, Wei W et al.. “Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases.” Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2025). PMID: 40048689 ↗

    L2bTRIAL_NONRANDOMCited in: Prognosis and Long-term Outcomes
  232. [232]

    Ehinger E, Darabi A, Visse E et al.. “Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial.” Trials (2025). PMID: 40083039 ↗

    L2bTRIAL_NONRANDOMCited in: Prognosis and Long-term Outcomes
  233. [233]

    Cliteur MP, Sondag L, Pegge SAH et al.. “The effect of minimally invasive intracerebral haematoma evacuation on early perihaematomal oedema formation.” European stroke journal (2026). PMID: 41614536 ↗

    L5OTHERCited in: Prognosis and Long-term Outcomes
  234. [234]

    Defante MLR, de Souza MM, Mendes BX et al.. “Subcutaneous rapid-acting insulin analogues in mild to moderate diabetic ketoacidosis: A meta-analysis of randomized controlled trials.” Journal of diabetes and its complications (2024). PMID: 39437698 ↗

    L1aSR_MA_RCTCited in: Special Populations
  235. [235]

    Zhou Y, Ding H, Liang H et al.. “Global research trends and emerging hotspots in acute high altitude illness: a bibliometric analysis and review (1937-2024).” Reviews on environmental health (2025). PMID: 40150970 ↗

    L2aSR_OBSCited in: Special Populations
  236. [236]

    Luks AM, Beidleman BA, Freer L et al.. “Wilderness Medical Society Clinical Practice Guidelines for the Prevention, Diagnosis, and Treatment of Acute Altitude Illness: 2024 Update.” Wilderness & environmental medicine (2024). PMID: 37833187 ↗

    L1cGUIDELINECited in: Special Populations
  237. [237]

    da Mota MF, de Amorim MM, Correia MDT et al.. “The optic nerve sheath in hypertensive disorders of pregnancy and perinatal outcomes: a cohort study.” BMC pregnancy and childbirth (2024). PMID: 39375707 ↗

    L2bCOHORTCited in: Special Populations
  238. [238]

    Small E, Goldberg E, Musi M et al.. “Prochlorperazine maleate versus placebo for the prevention of acute mountain sickness: study protocol for a randomized controlled trial.” Trials (2024). PMID: 39574186 ↗

    L2bTRIAL_NONRANDOMCited in: Special Populations
  239. [239]

    Zila-Velasque JP, Grados-Espinoza P, Goicochea-Romero PA et al.. “Mountain sickness in altitude inhabitants of Latin America: A systematic review and meta-analysis.” PloS one (2024). PMID: 39316567 ↗

    L2aSR_OBSCited in: Special Populations
  240. [240]

    Sieben N, Ramanan M. “Research Priorities for Diabetic Ketoacidosis: An Evidence and Gap Mapping Review.” Medical sciences (Basel, Switzerland) (2025). PMID: 40407548 ↗

    L5REVIEW_NARRATIVECited in: Special Populations
  241. [241]

    Manoharan MM, Montes GC, Acquarone M et al.. “Metabolic theory of preeclampsia: implications for maternal cardiovascular health.” American journal of physiology. Heart and circulatory physiology (2024). PMID: 38968164 ↗

    L5REVIEW_NARRATIVECited in: Special Populations
  242. [242]

    Gatterer H, Villafuerte FC, Ulrich S et al.. “Altitude illnesses.” Nature reviews. Disease primers (2024). PMID: 38902312 ↗

    L5REVIEW_NARRATIVECited in: Special Populations
  243. [243]

    Han C, Zheng XX, Zhang WF. “High altitude retinopathy: An overview and new insights.” Travel medicine and infectious disease (2024). PMID: 38295966 ↗

    L5REVIEW_NARRATIVECited in: Special Populations
  244. [244]

    Shinar S, Chitayat D, Shannon P et al.. “Fetal macrocephaly: Pathophysiology, prenatal diagnosis and management.” Prenatal diagnosis (2023). PMID: 38009873 ↗

    L5REVIEW_NARRATIVECited in: Special Populations
  245. [245]

    Kumar H, Bhakhri BK, Tyagi V et al.. “Characteristics and clinical relevance of leukocytic response in children with diabetic ketoacidosis - A comparative cohort study.” Archives of endocrinology and metabolism (2024). PMID: 39420911 ↗

    L2bCOHORTCited in: Special Populations
  246. [246]

    Omidi A, Hawley GD, Kain D et al.. “What Is New in Altitude- and Cold-Related Illnesses of Travel: Appraisal and Summary of the Updated Guidelines from the Wilderness Medical Society.” International journal of environmental research and public health (2025). PMID: 40003509 ↗

    L5REVIEW_NARRATIVECited in: Special Populations
  247. [247]

    Byard RW. “A forensic overview of deaths in mountainous terrain.” Forensic science, medicine, and pathology (2025). PMID: 39503975 ↗

    L5REVIEW_NARRATIVECited in: Special Populations
  248. [248]

    Leung KKY, Tung JYL, Lee YTK et al.. “A Narrative Review on Diabetic Ketoacidosis in Children.” Current pediatric reviews (2025). PMID: 38299411 ↗

    L5REVIEW_NARRATIVECited in: Special Populations
  249. [249]

    Derstine M, Jean D, Beidleman BA et al.. “Acute Mountain Sickness and High Altitude Cerebral Edema in Women: A Scoping Review-UIAA Medical Commission Recommendations.” High altitude medicine & biology (2023). PMID: 37870579 ↗

    L5REVIEW_NARRATIVECited in: Special Populations
  250. [250]

    Ni SY, Wang N, Luo DY et al.. “Discovery of novel salidroside derivatives as potent hypoxia inducible factor 1α (HIF-1α) signaling inhibitors to treat high altitude cerebral edema.” European journal of medicinal chemistry (2025). PMID: 40706447 ↗

    L5OTHERCited in: Special Populations
  251. [251]

    Fu Q, Qiu R, Tang Q et al.. “Exosomes from high-altitude cerebral edema patients induce cognitive dysfunction by altering oxidative stress responses in mice.” Translational psychiatry (2025). PMID: 40695777 ↗

    L5OTHERCited in: Special Populations
  252. [252]

    Patel M, Afifi AM, Hercher RL et al.. “Reevaluating bicarbonate therapy in pediatric DKA: A propensity score-matched analysis of neurological and respiratory outcomes.” The American journal of emergency medicine (2025). PMID: 40683034 ↗

    L5OTHERCited in: Special Populations
  253. [253]

    Lv W, Ma Y, Li D et al.. “Single-Cell RNA Sequencing and Spatial Transcriptomics Reveal a Novel Mechanism of Oligodendrocyte-Neuron Interaction in Cognitive Decline After High-Altitude Cerebral Edema.” CNS neuroscience & therapeutics (2025). PMID: 40546220 ↗

    L5OTHERCited in: Special Populations
  254. [254]

    DeMayo KM, Havlicek EE, Palumbo J et al.. “Diabetic Ketoacidosis and Venous Thromboembolism: A North American Virtual Pediatric Systems Registry Study, 2014-2023.” Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies (2025). PMID: 40439528 ↗

    L5OTHERCited in: Special Populations
  255. [255]

    Han Y, Li W, Duan H et al.. “Ligustrazine hydrochloride Prevents Ferroptosis by Activating the NRF2 Signaling Pathway in a High-Altitude Cerebral Edema Rat Model.” International journal of molecular sciences (2025). PMID: 39940878 ↗

    L5OTHERCited in: Special Populations
  256. [256]

    Bergman L, Hannsberger D, Schell S et al.. “Cerebral infarcts, edema, hypoperfusion, and vasospasm in preeclampsia and eclampsia.” American journal of obstetrics and gynecology (2025). PMID: 39486498 ↗

    L5OTHERCited in: Special Populations
  257. [257]

    Polymeris AA, Lioutas VA, Marchina S et al.. “Hemoglobin and Perihematomal Edema After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial.” Neurocritical care (2026). PMID: 40399657 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  258. [258]

    Hernández-Pérez M, Valls-Carbó A, Hernández-Jiménez M et al.. “Changes in Infarct Volume and Cerebral Edema After Mechanical Thrombectomy in Patients With Stroke Randomized to ApTOLL or Placebo: A Secondary Analysis of APRIL Trial.” Stroke (2025). PMID: 40677233 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  259. [259]

    Li S, Wang A, Shi L et al.. “Safety and efficacy of Angong Niuhuang Pills in patients with moderate-to-severe acute ischemic stroke (ANGONG TRIAL): A randomized double-blind placebo-controlled pilot clinical trial.” Chinese medical journal (2025). PMID: 39501831 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  260. [260]

    Liu X, Zhang X, Fan Y et al.. “Intraoperative goal-directed fluid management and postoperative brain edema in patients having high-grade gliomas resections: a randomized trial.” International journal of surgery (London, England) (2025). PMID: 39037734 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  261. [261]

    Huang X, Wang H, Ji Y et al.. “Incidence, predictors, and outcomes of malignant cerebral edema in acute basilar artery occlusion after endovascular treatment: a secondary analysis of the ATTENTION trial.” Journal of neurosurgery (2024). PMID: 38579342 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  262. [262]

    Witsch J, Cao Q, Song JW et al.. “Sex Differences in Perihematomal Edema Volume and Outcome After Intracerebral Hemorrhage.” Neurocritical care (2024). PMID: 38379104 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  263. [263]

    Sun D, Nguyen TN, Pan Y et al.. “Unsuccessful Recanalization versus Medical Management of Patients with Large Ischemic Core : Analysis of the ANGEL-ASPECT Randomized Trial.” Clinical neuroradiology (2024). PMID: 38319347 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  264. [264]

    Feng X, Zhang T, Wang N et al.. “Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial.” Stroke and vascular neurology (2024). PMID: 38191184 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  265. [265]

    Hayes WN, Laing E, Brown R et al.. “A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO).” Kidney international (2024). PMID: 37914088 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  266. [266]

    Zhu X, Han Q, Xia L et al.. “Efficacy of two hemodialyses in patients with chronic renal failure complicated by massive intracerebral hemorrhage.” Annals of clinical and translational neurology (2023). PMID: 37350299 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  267. [267]

    Li N, Guo J, Kang K et al.. “Cytotoxic Edema and Adverse Clinical Outcomes in Patients with Intracerebral Hemorrhage.” Neurocritical care (2023). PMID: 36180765 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  268. [268]

    Wang J, Xiong X, Zou J et al.. “Combination of Hematoma Volume and Perihematoma Radiomics Analysis on Baseline CT Scan Predicts the Growth of Perihematomal Edema.” Clinical neuroradiology (2023). PMID: 35943522 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  269. [269]

    Lee KH, Lioutas VA, Marchina S et al.. “The Prognostic Roles of Perihematomal Edema and Ventricular Size in Patients with Intracerebral Hemorrhage.” Neurocritical care (2022). PMID: 35676589 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  270. [270]

    Lombardo S, Smith MC, Semler MW et al.. “Balanced Crystalloid versus Saline in Adults with Traumatic Brain Injury: Secondary Analysis of a Clinical Trial.” Journal of neurotrauma (2022). PMID: 35443809 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  271. [271]

    Zhao W, Jiang F, Li S et al.. “Safety and efficacy of remote ischemic conditioning for the treatment of intracerebral hemorrhage: A proof-of-concept randomized controlled trial.” International journal of stroke : official journal of the International Stroke Society (2022). PMID: 33739197 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  272. [272]

    Maiwall R, Bajpai M, Singh A et al.. “Standard-Volume Plasma Exchange Improves Outcomes in Patients With Acute Liver Failure: A Randomized Controlled Trial.” Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association (2022). PMID: 33524593 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  273. [273]

    Lowe SL, Duggan Evans C, Shcherbinin S et al.. “Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging.” The journal of prevention of Alzheimer's disease (2021). PMID: 34585215 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  274. [274]

    Ng FC, Churilov L, Yassi N et al.. “Association between pre-treatment perfusion profile and cerebral edema after reperfusion therapies in ischemic stroke.” Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2021). PMID: 33993795 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  275. [275]

    Scheldeman L, Wouters A, Dupont P et al.. “Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion.” Stroke (2021). PMID: 33980046 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  276. [276]

    Mintun MA, Lo AC, Duggan Evans C et al.. “Donanemab in Early Alzheimer's Disease.” The New England journal of medicine (2021). PMID: 33720637 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  277. [277]

    Leasure AC, Kuohn LR, Vanent KN et al.. “Association of Serum IL-6 (Interleukin 6) With Functional Outcome After Intracerebral Hemorrhage.” Stroke (2021). PMID: 33682454 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  278. [278]

    Zusman BE, Kochanek PM, Bell MJ et al.. “Cerebrospinal Fluid Sulfonylurea Receptor-1 is Associated with Intracranial Pressure and Outcome after Pediatric TBI: An Exploratory Analysis of the Cool Kids Trial.” Journal of neurotrauma (2021). PMID: 33430695 ↗

    L1bRCTCited in: Landmark Trials and Key Evidence
  279. [279]

    Cook AM, Morgan Jones G, Hawryluk GWJ et al.. “Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.” Neurocritical care (2020). PMID: 32227294 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  280. [280]

    Ghannoum M, Laliberté M, Nolin TD et al.. “Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup.” Clinical toxicology (Philadelphia, Pa.) (2015). PMID: 25950372 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  281. [281]

    Spasovski G, Vanholder R, Allolio B et al.. “Clinical practice guideline on diagnosis and treatment of hyponatraemia.” European journal of endocrinology (2014). PMID: 24569125 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  282. [282]

    Spasovski G, Vanholder R, Allolio B et al.. “Clinical practice guideline on diagnosis and treatment of hyponatraemia.” Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2014). PMID: 24569496 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  283. [283]

    Wijdicks EF, Sheth KN, Carter BS et al.. “Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association.” Stroke (2014). PMID: 24481970 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  284. [284]

    Stravitz RT, Kramer AH, Davern T et al.. “Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group.” Critical care medicine (2007). PMID: 17901832 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  285. [285]

    Soffietti R, Cornu P, Delattre JY et al.. “EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force.” European journal of neurology (2006). PMID: 16834697 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  286. [286]

    Vahedi K, Proust F, Geeraerts T. “[Experts' recommendations for stroke management in intensive care: intracranial hypertension].” Revue neurologique (2012). PMID: 22571966 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  287. [287]

    Luks AM, Auerbach PS, Freer L et al.. “Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update.” Wilderness & environmental medicine (2019). PMID: 31248818 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  288. [288]

    Luks AM, McIntosh SE, Grissom CK et al.. “Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update.” Wilderness & environmental medicine (2014). PMID: 25498261 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  289. [289]

    Bennett BL, Hew-Butler T, Hoffman MD et al.. “Wilderness Medical Society practice guidelines for treatment of exercise-associated hyponatremia.” Wilderness & environmental medicine (2013). PMID: 23590928 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  290. [290]

    Luks AM, McIntosh SE, Grissom CK et al.. “Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness.” Wilderness & environmental medicine (2010). PMID: 20591379 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  291. [291]

    Liao KH, Chang CK, Chang HC et al.. “Clinical practice guidelines in severe traumatic brain injury in Taiwan.” Surgical neurology (2009). PMID: 19818476 ↗

    L1cGUIDELINECited in: Guidelines and Resources
  292. [292]

    Prasad GL, Pai A, Pt S. “Short course of low-dose steroids for management of delayed pericontusional edema after mild traumatic brain injury - A retrospective study.” Surgical neurology international (2025). PMID: 39926471 ↗

    L2bCOHORTCited in: Guidelines and Resources
  293. [293]

    Rapp A, Kobeissi H, Fahim DK. “Updated Review of the Management of and Guidelines for Traumatic Brain Injury.” Journal of clinical medicine (2025). PMID: 41095876 ↗

    L5REVIEW_NARRATIVECited in: Guidelines and Resources
  294. [294]

    Suarez JI. “Diagnosis and Management of Subarachnoid Hemorrhage.” Continuum (Minneapolis, Minn.) (2015). PMID: 26426230 ↗

    L5REVIEW_NARRATIVECited in: Guidelines and Resources
  295. [295]

    McBride DW, Szu JI, Hale C et al.. “Reduction of cerebral edema after traumatic brain injury using an osmotic transport device.” Journal of neurotrauma (2014). PMID: 24959845 ↗

    L5OTHERCited in: Guidelines and Resources
  296. [296]

    Hays AN, Lazaridis C, Neyens R et al.. “Osmotherapy: use among neurointensivists.” Neurocritical care (2011). PMID: 21153930 ↗

    L5OTHERCited in: Guidelines and Resources
  297. [297]

    Zusman BE, Kochanek PM, Jha RM. “Cerebral Edema in Traumatic Brain Injury: a Historical Framework for Current Therapy.” Current treatment options in neurology (2020). PMID: 34177248 ↗

    L5OTHERCited in: Guidelines and Resources
  298. [298]

    Schur S, Martel P, Marcoux J. “Optimal Bone Flap Size for Decompressive Craniectomy for Refractory Increased Intracranial Pressure in Traumatic Brain Injury: Taking the Patient's Head Size into Account.” World neurosurgery (2020). PMID: 32035212 ↗

    L5OTHERCited in: Guidelines and Resources

Revision History

All updates applied to this page

Loading revisions…